Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Long-term Safety and Efficacy of CartiFill After Microfracture Surgery in Knee Cartilage Defects

NCT: NCT07621172 · COMPLETED

NCT IDNCT07621172
StatusCOMPLETED
Start Date2020-02-03
Completion2021-04-27
SponsorCellontech Co., Ltd. (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this clinical trial is to evaluate the safety and efficacy of CartiFill implanted at the site of knee joint cartilage defect in a 6-year, long-term, follow-up investigation.

Frequently Asked Questions

What is Long-term Safety and Efficacy of CartiFill After Microfracture Surgery in Knee Cartilage Defects?

Long-term Safety and Efficacy of CartiFill After Microfracture Surgery in Knee Cartilage Defects is a clinical trial registered under NCT07621172. Current status: COMPLETED.

What is the status of NCT07621172?

The current status of NCT07621172 (Long-term Safety and Efficacy of CartiFill After Microfracture Surgery in Knee Cartilage Defects) is: COMPLETED.

When did Long-term Safety and Efficacy of CartiFill After Microfracture Surgery in Knee Cartilage Defects start?

Long-term Safety and Efficacy of CartiFill After Microfracture Surgery in Knee Cartilage Defects started on 2020-02-03.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.